[SharePad] Screening For My Next Long-Term Winner: Jupiter Fund Management

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

16 June 2019
By Maynard Paton

Today I have revisited a share screen that applies two ratios favoured by ‘quality’ investors — operating margin and return on equity (ROE).

The exact criteria I re-used were:

1) An operating margin (latest and 10-year average) of 20% or more, and;
2) An ROE (latest and 10-year average) of 20% or more.

This time I have pinpointed Jupiter Fund Management, a £1.7 billion fund manager with a mighty 41% operating margin and a robust 24% ROE.

Read my full Jupiter Fund Management article for SharePad.

Maynard Paton

[SharePad] Screening For My Next Long-Term Winner: Domino’s Pizza

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

24 May 2019
By Maynard Paton

My latest SharePad article covers one of the most impressive UK growth stocks of the last 20 years — Domino’s Pizza.

Domino’s appeared on my radar after I revisited one of my previous SharePad screens.

The screen in question searched for companies with dependable dividends and reasonable yields.

I selected Domino’s because I was already aware of the pizza chain’s dynamic growth history — and wondered why the shares had fallen to offer a useful, 4%-plus dividend income.

Read my full Domino’s Pizza article for SharePad.

Maynard Paton

Andrews Sykes: 2018 Results Show Profit Rising 18% To New High But Absence Of ‘Cautiously Optimistic’ Outlook Hints At Weaker 2019 Figures

22 May 2019
By Maynard Paton

Results verdict on Andrews Sykes (ASY):

  • Very favourable weather helped revenue gain 10% and profit jump 18% to set new records.
  • European sales soared 24% to represent almost a quarter of the business, and continue to offer further potential.
  • Accounts showcased wonderful margins, robust returns on equity, reassuring cash levels and respectable cash flow. 
  • Absence of “cautiously optimistic for further success” within management’s outlook hinted that 2019 may not be as buoyant as 2018.
  • The underlying P/E could be 16 while the yield is 3.3%. I continue to hold.

Read more

[SharePad] Screening For My Next Long-Term Winner: Abcam

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

10 May 2019
By Maynard Paton

For this SharePad search I re-used the screen I employed to pinpoint Victrex.

The filter focuses on two ratios favoured by ‘quality’ investors — operating margin and return on equity (ROE).

This time I selected Abcam, a £2.6 billion AIM company that develops and sells antibodies.

Abcam boasted a super 30% operating margin and a robust 20% ROE.

Read my full Abcam article for SharePad.

Maynard Paton

Getech: 2018 Results Showcase Impressive 24% Products Revenue Gain But Full Profit Recovery Remains Dependent On Stronger Oil Price

10 May 2019
By Maynard Paton

Results verdict on Getech (GTC):

  • Total revenue gained 11% to set the highest level since 2015. The dominant and more attractive Products division impressed with a 24% revenue improvement.
  • Progress was achieved in particular by a last-gasp $3.2m sale that contributed approximately 30% to the top line.
  • Profit was hampered by the loss-making Services division, although significant cost savings have since been made.
  • The direction of the oil price may largely dictate whether GTC’s oil-exploration software sells well (or not) during 2019.
  • The £11m market cap requires greater earnings to underpin obvious upside potential. I continue to hold.

Read more

Oleeo: 155-Word H1 Statement Could Strangely Mark The Low Point For Earnings As £13m Market Cap Compares To £11m Net Cash Position

07 May 2019
By Maynard Paton

Results verdict on Oleeo (OLEE):

  • A terse 155-word statement revealed an unsurprising 50% profit plunge as OLEE extends its “capacity to suffer” to four years.
  • At least revenue continues to inch ahead and might even be growing at a reasonable pace if the largest customer is excluded.
  • Recent client installations include all four Welsh police forces — cementing OLEE’s 50%-plus share of supplying UK police recruitment IT.
  • A lack of guidance for the full-year could strangely mark the low point for earnings. 
  • A £13m market cap is almost entirely supported by the £11m net cash position. I continue to hold.

Read more

[SharePad] Screening For My Next Long-Term Winner: Victrex

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

27 April 2019
By Maynard Paton

For this market trawl I employed two ratios favoured by ‘quality’ investors.

The first measure was operating margin, which represents the percentage of sales converted into profit.

The second measure was return on equity, or ROE, which is calculated by dividing earnings by the shareholder equity used to produce those earnings.

I used SharePad to identify a suitable company, and selected Victrex — a £2 billion specialist manufacturer of high-performance polymers — for further investigation.

Victrex offered a wonderful 39% operating margin and a robust 23% ROE.

Read my full Victrex article for SharePad.

Maynard Paton

M Winkworth: Franchisees Continue To Gain On Foxtons As Acceptable 2018 Figures Support Yield Of 6%

18 April 2019
By Maynard Paton

Results verdict on M Winkworth (WINK):

  • Collecting a greater proportion of franchisee estate-agent income supported an acceptable rate of growth.
  • Subdued sector conditions likely to persist until “relative [political] stability” emerges. 
  • Further market-share gains won from London rival Foxtons, while threat of online competition continues to subside.
  • Accounts still exhibit high margins, a cash-flush balance sheet and appealing returns on equity.
  • P/E of 11 and yield of 6% do not appear expensive should earnings resume their momentum. I continue to hold.

Read more

Bioventix: Bumper H1 Results Showcase ‘Modest’ 24% Growth As Renewed Troponin Optimism Helps Sustain 34x P/E

16 April 2019
By Maynard Paton

Results verdict on Bioventix (BVXP):

  • Very satisfactory 24% growth led by ongoing “modest” demand for the group’s vitamin D antibody.
  • Effect of terminated product licence may have obscured an underlying 28% revenue advance.  
  • Fledgling troponin product plus various pipeline developments offer intriguing long-term potential.  
  • First-class accounts continue to exhibit terrific margins, net cash and scope for further special dividends.
  • Valuation remains understandably rich with an underlying P/E of 34. I continue to hold.

Read more

[SharePad] Screening For My Next Long-Term Winner: Renishaw

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

15 April 2019
By Maynard Paton

I am convinced the very best shares to own are often led by executives who truly act in the interests of ordinary shareholders.

In particular, bosses who:

  • do not dilute investors by issuing shares willy-nilly;
  • create dependable returns through a rising dividend, and;
  • own a lot of shares themselves…

…should deliver better profits than ‘salarymen’ directors who care more about their wages, options and bonuses.

I employed SharePad to identify a suitable company — and selected Renishaw for further investigation.

Read my full Renishaw article for SharePad.

Maynard Paton

S & U: Record FY Results Show Dividend Up 12% But Management Hints Of Slowing Growth Leave Yield At 6%-Plus

05 April 2019
By Maynard Paton

Results verdict on S & U (SUS):

  • Satisfactory double-digit growth supported mostly by additional car loans issued during the first half.
  • Rising bad debts clearly indicate borrowers are no longer as profitable or reliable as they once were.
  • Improved first-payment rate suggests underwriting tweaks have started to curb future write-offs.
  • Reduced level of customer lending during the second half generated surplus cash and lowered group debt.
  • P/E of 10.7 and yield of 6.2% reflect management hints of slowing progress. I continue to hold.

Read more

Q1 2019: 1 Top-Up And Update On Plan For 2019

31 March 2019
By Maynard Paton

Happy Sunday! I hope you continue to find my Blog useful… and that your shares have rebounded following last year’s rough market.

My portfolio has advanced during the last three months — although not as much as the wider indices.

Notable price gains from Bioventix and FW Thorpe have been sadly offset by the ongoing collapse at Tasty and sluggish performances from many of my other holdings.  

The swings and roundabouts have meant that, for the first quarter, I am up only 3.9% versus a 9.5% gain enjoyed by the FTSE 100. 

Let me now explain what has happened within my portfolio during January, February and March.

Read more

FW Thorpe: H1 Results Confirm 10% Profit Drop As Cash Piles Up To New £53m Record

29 March 2019
By Maynard Paton

Results verdict on FW Thorpe (TFW):

  • Lower revenue and profit due to “challenging trading conditions” caused perhaps by the collapse of Carillion.
  • The statement’s highlight was management talk of orders having returned to “record levels”.
  • Fresh product developments continue and include “radical” new range of workplace lighting.
  • Accounts showcase huge £53m cash pile while dividend on course for 17th consecutive annual increase. 
  • Underlying P/E of 21 seems optimistic given recent progress. I continue to hold.

Read more

[SharePad] Screening For My Next Long-Term Winner: Craneware

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

27 March 2019
By Maynard Paton

I recently employed SharePad to identify a strong R&D-based business.

The exact SharePad criteria I used were:

  • An R&D-to-turnover ratio of 10% or more;
  • An operating margin of at least 10%, and;
  • Dividend growth for a minimum of five consecutive years.

SharePad returned only four matches.

I selected Craneware because, among those four shares, the company was the largest and offered the longest dividend record.

I was also vaguely aware of the business being renowned for some quality financials.

Read my full Craneware article for SharePad.

Maynard Paton

Tasty: Equity Placing On The Way As Results Offer Glimmers Of Hope Amid Further Losses And Significant Debt

22 March 2019
By Maynard Paton

Results verdict on Tasty (TAST):

  • Miserable figures blighted by debts and losses that confirmed — albeit within the small-print — that an equity placing is on the way.
  • The shares are now a gamble based on how much shareholders are asked to raise and at what price.
  • Second-half trading offered hope through greater cash generation alongside improved sales per restaurant and per employee.
  • Restaurants continue to be sold for cash although current trading was described as “slow”.
  • Market cap now £4.2m for sales of £47m and 58 restaurants. I continue to hold.

Read more

ABOUT ME

Investing in shares for 25+ years. Former share tipster. SharePad evangelist. Blogger. Webhost nerd. FIRE. Read more | Contact

PORTFOLIO

All holdings and buy prices. Latest trades. Quarterly updates. Annual returns since 2012. Purchases since 2004. Read more

SHAREPAD

The very best all-in-one research and data service for UK investors. Why I Use SharePad | Special blog offer

BLOG POST ALERTS

A simple link to every new blog post. No spam!

© maynardpaton.com 2024 • Disclaimer • Privacy • Contact